ADMA Biologics (NASDAQ: ADMA) director adds 6,400 shares in open-market buy
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ADMA Biologics director Jerrold B. Grossman reported buying 6,400 shares of common stock at $7.91 per share in an open-market transaction on May 27, 2026. Following this purchase, his directly held position, including 10,690 restricted stock units and 509,594 common shares, totaled 520,284 shares.
He also reported indirect holdings of ADMA common stock through several related entities and relationships: 175 shares held by Brookwood LLC, 38,294 shares held by the Jerrold Grossman 2019 Irrevocable Trust, 31,381 shares held by Genesis Foundation Inc., and 22,857 shares held by his wife.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,400 shares ($50,624)
Net Buy
5 txns
Insider
Grossman Jerrold B
Role
Director
Bought
6,400 shs ($51K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 6,400 | $7.91 | $51K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 520,284 shares (Direct);
Common Stock — 22,857 shares (Indirect, See footnote)
Footnotes (1)
- Represents an open market purchase in a single transaction. Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 509,594 shares of common stock owned by the Reporting Person. These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood. These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee. These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis. These shares are owned by the Reporting Person's wife.
Key Figures
Open-market purchase: 6,400 shares
Purchase price: $7.91 per share
Direct holdings after trade: 520,284 shares
+5 more
8 metrics
Open-market purchase
6,400 shares
Common stock bought on May 27, 2026
Purchase price
$7.91 per share
Price for 6,400 common shares
Direct holdings after trade
520,284 shares
Common shares plus RSUs after May 27, 2026
Common shares within direct holdings
509,594 shares
Owned directly by reporting person
Restricted stock units
10,690 RSUs
Granted February 9, 2026, vesting in 2026 and 2027
Indirect Brookwood LLC shares
175 shares
Held by Brookwood LLC, where he is managing member
Indirect trust holdings
38,294 shares
Held by Jerrold Grossman 2019 Irrevocable Trust
Indirect Genesis and spouse holdings
54,238 shares
31,381 via Genesis Foundation Inc. and 22,857 via spouse
Key Terms
open market purchase, RSUs, restricted stock units, indirect ownership, +1 more
5 terms
open market purchase financial
"Represents an open market purchase in a single transaction."
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
RSUs financial
"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
restricted stock units financial
"10,690 RSUs granted on February 9, 2026, half of which will vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect ownership financial
"These shares are owned by Brookwood LLC, the trust, Genesis, or his wife."
irrevocable trust financial
"These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
FAQ
What insider transaction did ADMA (ADMA) report for Jerrold B. Grossman?
ADMA disclosed that director Jerrold B. Grossman bought 6,400 shares of common stock in an open-market transaction. The shares were purchased on May 27, 2026 at a price of $7.91 per share, increasing his directly reported holdings.
What restricted stock units (RSUs) are reported for the ADMA (ADMA) director?
Grossman’s direct holdings include 10,690 RSUs granted on February 9, 2026. Half of these RSUs will vest on August 9, 2026 and the remaining half on February 9, 2027, provided he continues to serve through each vesting date.
Is the ADMA (ADMA) director’s transaction a purchase or sale?
The Form 4 shows an open-market purchase by Jerrold B. Grossman. He acquired 6,400 ADMA common shares on May 27, 2026, coded as a “P” transaction, which denotes a purchase in the open market or a private transaction under SEC rules.